Melanotan II is illegal to sell in the United States, United Kingdom, and Australia. One of the primary problems with tanning nasal spray products is that the ingredients are not approved by the Food ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

Police used pepper spray to subdue a man who they arrested on suspicion of drug offences on Seven Mile Beach. He is the third man to be arrested for such offences in the past week. According to ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The drug is still considered effective in nasal sprays, though those are much less popular. Phenylephrine wasn’t always the top choice for cold and allergy products. Many were originally ...

Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...

The nasal bones are two wedged-shaped bones that make up the bridge of your nose. They come together at a rigid fibrous joint, forming the thickest part of the nose. Trauma to the face often involves ...

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.